1. Nanoengineered 3D-printing scaffolds prepared by metal-coordination self-assembly for hyperthermia-catalytic osteosarcoma therapy and bone regeneration.
- Author
-
Huang B, Li G, Cao L, Wu S, Zhang Y, Li Z, Zhou F, Xu K, Wang G, and Su J
- Subjects
- Humans, Metal-Organic Frameworks chemistry, Metal-Organic Frameworks pharmacology, Metal-Organic Frameworks chemical synthesis, Surface Properties, Copper chemistry, Copper pharmacology, Hyperthermia, Induced, Tissue Engineering, Particle Size, Catalysis, Animals, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry, Mice, Cell Survival drug effects, Nanostructures chemistry, Cell Line, Tumor, Cell Proliferation drug effects, Osteosarcoma pathology, Osteosarcoma drug therapy, Osteosarcoma therapy, Bone Regeneration drug effects, Printing, Three-Dimensional, Tissue Scaffolds chemistry, Bone Neoplasms pathology, Bone Neoplasms drug therapy, Bone Neoplasms therapy, Polyesters chemistry
- Abstract
The integration of functional nanomaterials with tissue engineering scaffolds has emerged as a promising solution for simultaneously treating malignant bone tumors and repairing resected bone defects. However, achieving a uniform bioactive interface on 3D-printing polymer scaffolds with minimized microstructural heterogeneity remains a challenge. In this study, we report a facile metal-coordination self-assembly strategy for the surface engineering of 3D-printed polycaprolactone (PCL) scaffolds with nanostructured two-dimensional conjugated metal-organic frameworks (cMOFs) consisting of Cu ions and 2,3,6,7,10,11-hexahydroxytriphenylene (HHTP). A tunable thickness of Cu-HHTP cMOF on PCL scaffolds was achieved via the alternative deposition of metal ions and HHTP. The resulting composite PCL@Cu-HHTP scaffolds not only demonstrated potent photothermal conversion capability for efficient OS ablation but also promoted the bone repair process by virtue of their cell-friendly hydrophilic interfaces. Therefore, the cMOF-engineered dual-functional 3D-printing scaffolds show promising potential for treating bone tumors by offering sequential anti-tumor effects and bone regeneration capabilities. This work also presents a new avenue for the interface engineering of bioactive scaffolds to meet multifaceted demands in osteosarcoma-related bone defects., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF